Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

SciClone and Schering-Plough begin phase III trial of Zadaxin in Japan

May 18, 1998

Pharmacological profile of lafutidine and related compounds

May 15, 1998

Selective somatostatin receptor antagonist reported for pancreatic disorders

May 12, 1998

Compounds for GI tract motility disorders claimed by Yamanouchi

May 11, 1998

Peptide Therapeutics and Pasteur Merieux-OraVax to develop H. pylori vaccine

May 8, 1998

More European approvals obtained for balsalazide

May 8, 1998

Combination therapy incorporating antioxidants effective for treatment of H. pylori infection

May 8, 1998

YF-476, a potent gastrin/CCK-B antagonist with gastric antisecretory activity

May 7, 1998

Cyclic amines active against H. pylori in development at Takeda

May 7, 1998

FDA advisory committee recommends approval of drug combination for hepatitis C

May 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...